Team
The VRI includes 150 researchers working on more than 40 international projects.
Gérard Zurawski
He has been an Investigator at the Baylor Institute for Immunology Research (BIIR) since 2004 and is currently a BIIR Co-Director and Director for the BIIR Center for Biotechnology.
He trained as a bacterial geneticist and received his Ph.D. from the Sydney University in Australia and trained in Molecular Biology at Stanford University, California and the C.S.I.R.O., Canberra.
He is an expert in Molecular Biology and Protein Engineering, specializing in the immune system. He directed the DNAX Genomics Division and he identified and characterized cytokines and their receptor interactions, including IL-13, and IL-25. At BIIR, he has led a vaccine-development program based on targeting antigens directly to human dendritic cells using antibody-antigen conjugates. The BIIR team, joined the VRI since 2012 to pursue the development of this platform according to the VRI strategy.